SITUS JUDI MBL77 NO FURTHER A MYSTERY

mutations provided The point that, as spelled out underneath, CLL therapy is based over the existence or absence of such mutations. The current consensus is the fact that, in addition to clonal mutations, subclonal mutations with a variant allelic frequency starting from 5 to ten% (and so down below the brink of detection by regular molecular strat